VivoSim Lab, Inc.(VIVS)
盘前1.280.08+6.67%06:00 EDT
1.20-0.15-11.11%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称VivoSim Lab, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况VivoSim Labs, Inc.成立于2012年1月，从事开发和商业化可以应用在药物发现和开发，进行生物学研究，作为植入受损或退化组织和器官的治疗的人体组织技术平台。VivoSim计划引进到三维人体组织，通过构建三维创作，复制天然人类生物学的潜力。- 04-06Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors超过5%披露Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 04-04Form 8-K - Current report重要事件披露Form 8-K - Current report
- 04-01Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 04-01Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 03-31Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend][修订]招股说明书Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 03-31Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 03-31Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 03-28Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 03-28Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 03-27Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 02-12Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-12-19Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-06Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-29Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-08-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
1.35
今开
1.32
量比
3.29
最低
1.18
昨收
1.35
换手率
7.02%